Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21

<p>Abstract</p> <p>Introduction</p> <p>We have shown that the radio sensitizer DCQ enhances sensitivity of HCT116 human colon cancer cells to hypoxia. However, it is not known whether the p53 or p21 genes influence cellular response to DCQ. In this study, we used HCT116...

Full description

Bibliographic Details
Main Authors: Haddadin Makhluf J, Geara Fady, El-Khatib Mona, Gali-Muhtasib Hala
Format: Article
Language:English
Published: BMC 2010-11-01
Series:Radiation Oncology
Online Access:http://www.ro-journal.com/content/5/1/107
_version_ 1818473038778204160
author Haddadin Makhluf J
Geara Fady
El-Khatib Mona
Gali-Muhtasib Hala
author_facet Haddadin Makhluf J
Geara Fady
El-Khatib Mona
Gali-Muhtasib Hala
author_sort Haddadin Makhluf J
collection DOAJ
description <p>Abstract</p> <p>Introduction</p> <p>We have shown that the radio sensitizer DCQ enhances sensitivity of HCT116 human colon cancer cells to hypoxia. However, it is not known whether the p53 or p21 genes influence cellular response to DCQ. In this study, we used HCT116 that are either wildtype for p53 and p21, null for p53 or null for p21 to understand the role of these genes in DCQ toxicity.</p> <p>Methods</p> <p>HCT116 cells were exposed to DCQ and incubated under normoxia or hypoxia and the viability, colony forming ability, DNA damage and apoptotic responses of these cells was determined, in addition to the modulation of HIF-1α and of p53, p21, caspase-2, and of the ataxia telangiectasia mutated (ATM) target PIDD-C.</p> <p>Results</p> <p>DCQ decreased colony forming ability and viability of all HCT116 cells to a greater extent under hypoxia than normoxia and the p21<sup>-/-</sup>cell line was most sensitive. Cells had different HIF-1α responses to hypoxia and/or drug treatment. In p53<sup>+/+</sup>, DCQ significantly inhibited the hypoxia-induced increases in HIF-1α protein, in contrast to the absence of a significant HIF-1α increase or modulation by DCQ in p21<sup>-/- </sup>cells. In p53<sup>-/- </sup>cells, 10 μM DCQ significantly reduced HIF-1α expression, especially under hypoxia, despite the constitutive expression of this protein in control cells. Higher DCQ doses induced PreG<sub>1</sub>-phase increase and apoptosis, however, lower doses caused mitotic catastrophe. In p53<sup>+/+ </sup>cells, apoptosis correlated with the increased expression of the pro-apoptotic caspase-2 and inhibition of the pro-survival protein PIDD-C. Exposure of p53<sup>+/+ </sup>cells to DCQ induced single strand breaks and triggered the activation of the nuclear kinase ATM by phosphorylation at Ser-1981 in all cell cycle phases. On the other hand, no drug toxicity to normal FHs74 Int human intestinal cell line was observed.</p> <p>Conclusions</p> <p>Collectively, our findings indicate that DCQ reduces the colony survival of HCT116 and induces apoptosis even in cells that are null for p53 or p21, which makes it a molecule of clinical significance, since many resistant colon tumors harbor mutations in p53.</p>
first_indexed 2024-04-14T04:16:16Z
format Article
id doaj.art-5f9e3e514bba47319d59a3fd93076d59
institution Directory Open Access Journal
issn 1748-717X
language English
last_indexed 2024-04-14T04:16:16Z
publishDate 2010-11-01
publisher BMC
record_format Article
series Radiation Oncology
spelling doaj.art-5f9e3e514bba47319d59a3fd93076d592022-12-22T02:12:48ZengBMCRadiation Oncology1748-717X2010-11-015110710.1186/1748-717X-5-107Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21Haddadin Makhluf JGeara FadyEl-Khatib MonaGali-Muhtasib Hala<p>Abstract</p> <p>Introduction</p> <p>We have shown that the radio sensitizer DCQ enhances sensitivity of HCT116 human colon cancer cells to hypoxia. However, it is not known whether the p53 or p21 genes influence cellular response to DCQ. In this study, we used HCT116 that are either wildtype for p53 and p21, null for p53 or null for p21 to understand the role of these genes in DCQ toxicity.</p> <p>Methods</p> <p>HCT116 cells were exposed to DCQ and incubated under normoxia or hypoxia and the viability, colony forming ability, DNA damage and apoptotic responses of these cells was determined, in addition to the modulation of HIF-1α and of p53, p21, caspase-2, and of the ataxia telangiectasia mutated (ATM) target PIDD-C.</p> <p>Results</p> <p>DCQ decreased colony forming ability and viability of all HCT116 cells to a greater extent under hypoxia than normoxia and the p21<sup>-/-</sup>cell line was most sensitive. Cells had different HIF-1α responses to hypoxia and/or drug treatment. In p53<sup>+/+</sup>, DCQ significantly inhibited the hypoxia-induced increases in HIF-1α protein, in contrast to the absence of a significant HIF-1α increase or modulation by DCQ in p21<sup>-/- </sup>cells. In p53<sup>-/- </sup>cells, 10 μM DCQ significantly reduced HIF-1α expression, especially under hypoxia, despite the constitutive expression of this protein in control cells. Higher DCQ doses induced PreG<sub>1</sub>-phase increase and apoptosis, however, lower doses caused mitotic catastrophe. In p53<sup>+/+ </sup>cells, apoptosis correlated with the increased expression of the pro-apoptotic caspase-2 and inhibition of the pro-survival protein PIDD-C. Exposure of p53<sup>+/+ </sup>cells to DCQ induced single strand breaks and triggered the activation of the nuclear kinase ATM by phosphorylation at Ser-1981 in all cell cycle phases. On the other hand, no drug toxicity to normal FHs74 Int human intestinal cell line was observed.</p> <p>Conclusions</p> <p>Collectively, our findings indicate that DCQ reduces the colony survival of HCT116 and induces apoptosis even in cells that are null for p53 or p21, which makes it a molecule of clinical significance, since many resistant colon tumors harbor mutations in p53.</p>http://www.ro-journal.com/content/5/1/107
spellingShingle Haddadin Makhluf J
Geara Fady
El-Khatib Mona
Gali-Muhtasib Hala
Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
Radiation Oncology
title Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
title_full Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
title_fullStr Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
title_full_unstemmed Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
title_short Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
title_sort cell death by the quinoxaline dioxide dcq in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
url http://www.ro-journal.com/content/5/1/107
work_keys_str_mv AT haddadinmakhlufj celldeathbythequinoxalinedioxidedcqinhumancoloncancercellsisenhancedunderhypoxiaandisindependentofp53andp21
AT gearafady celldeathbythequinoxalinedioxidedcqinhumancoloncancercellsisenhancedunderhypoxiaandisindependentofp53andp21
AT elkhatibmona celldeathbythequinoxalinedioxidedcqinhumancoloncancercellsisenhancedunderhypoxiaandisindependentofp53andp21
AT galimuhtasibhala celldeathbythequinoxalinedioxidedcqinhumancoloncancercellsisenhancedunderhypoxiaandisindependentofp53andp21